Congratulations to Drs. Maojin Yao and Ying Jiang for the start of a NIH R01 to study immunological tumor microenvironment in medulloblastoma – a job well done!
April 2016 – Maojin & Ying’s NIH R01 on medulloblastoma TME started
August 15, 2018 by zrb8mf@virginia.edu